West Pharmaceutical Services, Inc. (WST)

USD 325.32

(-2.67%)

Annual Balance Sheets

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 3.82 Billion 3.61 Billion 3.31 Billion 2.79 Billion 2.34 Billion 1.59 Billion
Total Current Assets 1.93 Billion 1.91 Billion 1.74 Billion 1.37 Billion 1.05 Billion 894.4 Million
Cash And Short Term Investments 853.9 Million 894.3 Million 762.6 Million 615.5 Million 439.1 Million 337.4 Million
Cash and Cash Equivalents 853.9 Million 894.3 Million 762.6 Million 615.5 Million 439.1 Million 337.4 Million
Short Term Investments - - - - - -
Net Receivables 512 Million 507.4 Million 489 Million 385.3 Million 319.3 Million 288.2 Million
Inventory 434.7 Million 414.8 Million 378.4 Million 321.3 Million 235.7 Million 214.5 Million
Other Current Assets 135.8 Million 103 Million 112 Million 51.6 Million 64.6 Million 54.3 Million
Total Non-Current Assets 1.89 Billion 1.69 Billion 1.57 Billion 1.42 Billion 1.28 Billion 1.08 Billion
Net PPE 1.51 Billion 1.26 Billion 1.12 Billion 1.01 Billion 909.4 Million 822 Million
Good Will And Intangible Assets 123.6 Million 125.7 Million 132.9 Million 141.6 Million 137.6 Million 126.2 Million
Good Will 108.5 Million 107.3 Million 109.9 Million 111.1 Million 107.8 Million 105.8 Million
Intangible Assets 15.1 Million 18.4 Million 23 Million 30.5 Million 29.8 Million 20.4 Million
Long-Term Investments 210 Million 204.9 Million 207.7 Million 214.7 Million 192.7 Million 91.2 Million
Tax Assets 25.7 Million 65.6 Million 48.5 Million 16 Million 14 Million 24.7 Million
Other Non Current Assets 21.3 Million 38.4 Million 55.9 Million 36.3 Million 29 Million 20.5 Million
Other Assets - - - - - -386.6 Million
Total Liabilities 948.5 Million 931.9 Million 978.4 Million 939.3 Million 768.2 Million 196.1 Million
Total Current Liabilities 671.8 Million 519 Million 594.1 Million 503.4 Million 341.6 Million 283.7 Million
Account Payables 242.4 Million 215.4 Million 232.2 Million 213.1 Million 156.8 Million 130.4 Million
Tax Payables 31 Million 38.5 Million 39.3 Million 41.4 Million 12.9 Million 9.8 Million
Short Term Debt 151.7 Million 18.2 Million 53.5 Million 12.4 Million 11.9 Million 100 Thousand
Deferred Revenue 41.7 Million 57.3 Million 48.7 Million 51 Million 27.5 Million 25.5 Million
Other Current Liabilities 236 Million 228.1 Million 259.7 Million 226.9 Million 145.4 Million 127.7 Million
Total Non Current Liabilities 276.7 Million 412.9 Million 384.3 Million 435.9 Million 426.6 Million 298.9 Million
Long-Term Debt 157.3 Million 299.7 Million 271.8 Million 313.3 Million 317.4 Million 196 Million
Deferred Revenue Non Current 48.2 Million 2.1 Million 69.4 Million 80.4 Million 52.5 Million 56.2 Million
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 58.5 Million 96.8 Million 38.2 Million 31.8 Million 41.2 Million 33.6 Million
Other Liabilities - - - - - -386.5 Million
Total Equity 2.88 Billion 2.68 Billion 2.33 Billion 1.85 Billion 1.57 Billion 1.39 Billion
Stock Holders Equity 2.88 Billion 2.68 Billion 2.33 Billion 1.85 Billion 1.57 Billion 1.39 Billion
Common Stock 18.8 Million 18.8 Million 18.8 Million 18.8 Million 18.8 Million 18.8 Million
Retained Earnings 3.52 Billion 2.98 Billion 2.45 Billion 1.84 Billion 1.54 Billion 1.35 Billion
Accumulated other comprehensive income -143.8 Million -183 Million -159.6 Million -110.6 Million -149.6 Million -154.2 Million
Common Stock Equity 2.88 Billion 2.68 Billion 2.33 Billion 1.85 Billion 1.57 Billion 1.39 Billion
Capital Lease Obligation 102.2 Million 109 Million 72.3 Million 70.5 Million 72 Million -
Total Investments 210 Million 204.9 Million 207.7 Million 214.7 Million 192.7 Million 91.2 Million
Total Debt 309 Million 317.9 Million 325.3 Million 325.7 Million 329.3 Million 196.1 Million
Net Debt -544.9 Million -576.4 Million -437.3 Million -289.8 Million -109.8 Million -141.3 Million

Balance Sheet Charts